Institutions / Fcpm III Services B.V.
Fcpm III Services B.V.
CIK 2013410 · Institution · as of Dec 31, 2025
Portfolio value
$762.89M
Positions
10
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Newamsterdam Pharma Company | $322.70M | 42.3% |
| Dyne Therapeutics, Inc. | $106.85M | 14.0% |
| enGene Therapeutics Inc. | $86.98M | 11.4% |
| Rapt Therapeutics Inc | $62.09M | 8.1% |
| Maplight Therapeutics IncMPLT | $56.67M | 7.4% |
| Vor Biopharma Inc. | $47.31M | 6.2% |
| Replimune Group, Inc. | $27.30M | 3.6% |
| Bicycle Therapeutics plcBCYC | $24.56M | 3.2% |
| Crescent Biopharma, Inc. | $19.90M | 2.6% |
| Engene Holdings Inc | $8.52M | 1.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.